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Introduction
Steroid Sa-reductase catalyzes the conversion of testosterone into the hormonally more effective Sa-dihydrotestosterone in androgen target tissues. It therefore represents the key enzyme in androgen-mediated effects (21). In previous studies (12), we have tried isolating the enzyme from female rat liver, where it is present at relatively high amounts. Altematively, isolation was attempted from rat ventral prostate, where the enzyme resides at comparably low activity in the outer nuclear membrane, or the adjacent rough endoplasmic reticulum (10-12). However, biochemical isolation from rat or human prostate, was impossible without almost complete loss of enzyme activity and was therefore not further pursued as a means of antigen preparation.
A new approach for antigen preparation was made possible by the molecular cloning ofthe cDNA coding for the enzyme by Andersson et al. (3) . In previous experiments we s h m d that C-terminal Supported by grant AU 48/7-10 from the Deutsche Forschungsgemeinschaft and by grant W6/W Au 1 from the Deutsche Krebshilfe. peptides, deduced from rat liver cDNA sequence, were useful in producing specific antibodies to rat Sa-reductase (7-9). The resulting antibodies strongly stained rat liver hepatocytes but showed rather ambiguous results in the rat prostate. The molecular analyses of human and rat prostatic and hepatic cDNAs of Sa-reductase performed by Anderson et al. (2) and Normington and Russell (20) showed the existence of different isoenzymes of Sa-reductase, explaining the lacking immunological crossreactivity between rat liver, rat prostate, and human prostate enzymes. In the present study, antibodies directed against synthetic peptide fragments corresponding to the C-terminus of human Sa-reductase 2 were applied to several human androgen target and non-target tissues to identlfy the presence and distribution of this key enzyme of androgen metabolism in the respective tissues.
The human prostate enzyme (Type 2) recently gained the particular interest of urologists because of the adability of specific Sa-reductase inhibitors. These do not interfere with the androgen receptor system and are therefore regarded as highly effective in the treatment of benign prostatic hyperplasia (22,27). The latter is an androgen-dependent process that has been ascribed to increased Sa-reductase activities in the prostate (for review see IS). With respect to the potential application of Sa-reductase inhibitors in the treatment of androgen-dependent diseases, the study of tissue dis-tribution of the respective enzyme, its subcellular localization, and its potential sexually dimorphic distribution became of interest.
Materials and Methods
Peptide Synthesis. A peptide consisting of 12 amino acids (amino acids 234-245 of human prostate Sa-reductase 2). as deduced from the cDNA sequence (2), with a C-terminal cystein residue added, was linked to keyhole limpet hemocyanin (KLH) with 3-maleimido-benzoic acid-hydroxysuccinimido ester as a coupling reagent (17). Alternatively, eight molecules of the peptide were synthesized onto a branched lysine core, resulting in a octameric multiple antigen peptide (MAP) (1, 26) . Both syntheses were performed with an SMPS peptide synthesizer (Simultaneous Multiple Peptide Synthesizer; Zinser Analytic, Frankfurt, Germany). In addition, nonconjugated peptide (amino acids 229-254) was used for immunization. Purity of the synthetic peptides was checked by reverse phase HPLC and capillary zone electrophoresis. The correct sequences were proofed by automated gas phase sequencing and amino acid analysis.
Immunization and Antibody Characterization. Aliquots (100 pg) of the native, MAP-, or KLH-conjugated peptide were mixed with 400 p1 of Freund's adjuvant in water (l:l, v/v) and injected sc to the dorsal skin of female rabbits (New Zealand strain, body weight 3 kg). Five animals were used for each group (native; KLH-conjugated = group K; MAP-conjugated = group L). Booster injections (100-pg aliquots of peptide, using incomplete Freund's adjuvant as a vehicle) were given four times at 3-week intervals. Animals were bled from an ear artery before the immunization and 12 days after each booster injection. Blood serum from 5-ml samples was aspirated after dotting and stored deep-frozen until use. Sera were designated L (for MAP conjugation) or K (for KLH conjugation), followed by the number of the respective animal and booster sample; e.g. L1-4 means MAP-conjugated antigen injected animal No. 1, serum taken after the fourth booster injection. For immunohistochemical procedures, antibodies were isolated from sera by affinity chromatography with a protein A-Sepharose fast flow column (Pharmacia; Freiburg, Germany). Serum (0.3 ml) was diluted 1:3 in PBS, sterile-filtered, and passed several times over 1.2-ml resin. The unbound fraction was collected and, after extensive washing of the resin with PBS, antibodies were eluted with glycine buffer (100 mM, pH 3) and collected in 1/10 volume of Tris-HC1 buffer (1 M, pH 8) . The antibody fractions were checked for purity by SDS-PAGE.
Specificity
Tests. An antibody-capture ELISA test was used for control of specificity. Native peptide or MAP-conjugated peptide, as well as a synthetic peptide fragment of rat liver Sa-reductase 1 and human Sa-reductase 1, were bound to microtiter plates (Maxisorb; Nunc, Roskilde, Denmark) (100 ng/well, incubation at 4'C overnight). Sera were serial-diluted in PBS and incubated for 70 min at 37'C. After thorough washing with PBS, the secondary antibody (swine anti-rabbit IgG, alkaline phosphatase-conjugated) (Dako; Glomp, Denmark) diluted 1:lOOO in PBS was added and incubated for 30 min at 37'C. After washing, bound antibody was quantified by incubation (50 min at 2 l T ) withp-nitrophenylphosphate dissolved in glycine 100 mM, MgCl 1 mM, ZnC12 1 mM, pH 10.4, at a concentration of 1 mglml.
Absorbance (&05/630) was recorded in an ELISA reader system (Dynatech; Denkendorf, Germany). Control incubations were performed by using the respective pre-immune serum in place of the specific antibody or by omitting the specific antigen on the microtiter plate. For plotting of the results, double measurements were averaged and the control value was subtracted from the respective experimental value.
Western blotting was done as a second approach for antibody testing. Membrane fractions of prostate tissues were prepared by centrifugation. Tissue samples were homogenized with an ultraturrax uahnke & Kunkel; Staufen, Germany) in Hepes buffer (5 mM, pH 7.4) , 250 mM sucrose, 1 mM EDTA, filtered through nylon gauze, and centrifuged at 100,000 x g for 1 hr. Aliquots equaling 25 pg of protein [determined according to the method of Bradford (6) ] were applied to 7.5-20% polyacrylamide gels (16) and electrophoretically transblotted to nitmcellulose membranes (28). Membranes were immersed in blocking buffer (5 % non-fat dry milk in Tris-HC1 buffer, 100 mM, pH 7.5) for 30 min at 37'C and incubated with sera diluted in blocking buffer ovemight at 4'C. Immunodetection of the respective antigen bands was performed by using biotinylated anti-rabbit IgG (1:500) (Amersham; Aylesbury, UK), followed by streptavidin-biotinylated peroxidase complex (1750) (Amersham) which were applied for 45 min each at room temperature (RT). Visualization ofthe immunocomplavs was done with the Enhanced Chemiluminescence System (EU, Amersham).
Tissues. Tissue samples were taken from the files of the Department of Anatomy and Cell Biology, derived mainly from patients undergoing surgery or from autopsies. In a few cases, only specimens from routine autopsies from the Department of Pathology were available. All specimens were fixed in buffered 4% formaldehyde. For comparison, the prostate tissue obtained during open prostatectomy (courtesy of Prof. P. Funke, Siegen. and Prof. H. Melchior, b e l ) was shock-frozen in liquid nitrogen and sectioned on a cryostat. Immunoreactions were performed on fixed and unfiied cryostat sections and were compared to the results on paraffin sections.
Immunohistochemical Procedures. Paraffin-embedded specimens were cut at 5-pm thickness, mounted on poly-Llysine-coated slides, dried overnight at 40"C, d e p d i n i z e d in xylene, and rehydrated. Endogenous peroxidase was blocked with 3% Hz02 in H20 for 15 min. After blocking with BSA (1% w/v in PBS), sections were incubated overnight at 4'C with the respective purified antibodies (1.6-8 pg/ml in PBS containing 0.5 % BSA). Sections were washed three times for 5 min with PBS. 0.05% Tween 20 (PBSIT), covered with diluted (1:200) anti-rabbit IgG (Dako). and incubated for 45 min at RT. After thorough rinsing in PBSIT, PAP complex diluted 1:lOO was applied for 30 min at RT. The sections were once again rinsed in PBSlT and then incubated with 10 mg of 3,Y-diaminobenzidine (DAB) dissolved in 100 ml PBS containing 0.03% HzOz for 15 min at RT. No counterstain was performed. Sections were dehydrated and mounted in resin. As a negative control, antibodies isolated from the respective pre-immune serum were used at the same concentration as the relew.cn antibody. Results were negative if not otherwise stated.
Results

Antibody Characterization and Specificity Tests
ELISA Assays. All immunized rabbits produced antibodies against the respective peptide antigen (KLH conjugate, MAP conjugate, unconjugated peptide) with high titers. High crossreactivity between the different groups was observed at a level of about 80% of the reaction with the original antigen preparation. Titers already reached a plateau value after the first booster injection. No further increase was observed even after the fourth booster injection. Testing the pre-immune sera, no reactions were observed with either the native or the conjugated antigen. Likewise, no immunoreaction occurred in control incubations of the antisera when the antigen had been omitted. No crossreactivity of the antisera with human prostate Sa-reductase Type 1 peptide was found. The antisera were therefore regarded as highly specific for human Type 2 5areductase (Tible 1). To test the antisera with the authentic enzyme, ELISAs were performed with microsomes prepared from benign prostate tissue (containing Sa-reductase activity) or cytosol from the same source (free of detectable enzyme activity). In contrast to the previously published antibody against rat liver Sa-reductase 
, no clear-cut results were obtained with the human antibodies.
Obviously. these antibodies recognize the antigenic epitopes only in the denatured protein.
Westem Blomng. Using sera of animals injmed with the MAP antigen. human prostate microsomes revealed an immunoreactive band at 26 KD that was absent when pre-immune serum was used. However. bands at 50 KD and >lo0 KD were present. with both pre-immune and immune sera. They were regarded as nonspecific.
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. lmmunobloning analysis of human prostatic microsomes wtth Sareductase 2 antisera Lsp. K5-4. and the respective preimmune sera P-L5 and P-KS. Serum G1 was raised against human Sa-reductase 1. It is shown to demonstrate isoenzyme specificity of the sera. Migration distances of marker proteins of the indicated molecular weight are shown on the left-hand side. With L54 and K54. Sa-reductase 2 with an apparent MW weight of 26 KD is detected (arrow); this protein is not stained with the respective praimmune serum. 5a-Reductase 1. with an apparent MW of 23 KD. is marked with the specific antibody G1 (amhead). It is not detected with the praimmune serum P G 1 or with serum L5-4 or K5-4. Higher molecular weight proteins are detected by serum L54 and the respective pre-immune serum and are therefore regarded as nonspecific.
As control incubations with the pre-immune sera were performed with every immunocytochemical reaction, the higher molecular weight proteins were shown as irrelevant (Figure 2B) . Reactions were nearly identical with sera from rabbits immunized with KLHconjugated or native peptide antigen. In general, the immunoreactions were weak. requiring a long time of exposure of the X-ray film (up to 45 min) with the ECL system ( Figure 1 ).
Tissue Distribution
Methodology. All the antisera were applied to native or acetonefuced cryostat sections and to panffin sections of human prostate. The reaction pattern showed individual differences concerning sensitivity but was relatively homogeneous with regard to Specificity. Dilution experiments (1:IO-1:800) and absorption experiments with the peptide antigen were done to identify the serum with highest specificity. Serum L5-4 was selected and used for tissue screening ( Table 2) .
Male Genital System. Positive staining was xen in prostate epithelium (especially in basal cells), seminal vesicle epithelium (Figures 2A and 2C) , and epididymal epithelium. Smooth muscle cells and fibrocytes in both glands showed a less intense immunoreaction. In testis, only spermatogonia displayed some immunoreactivity, whereas in Leydig cells, peritubular cells, and Sertoli cells a nonspecific background staining developed. also visible with the pre-immune serum (not shown).
Female Gmital System. A faint immunoreaction occurred in germinal epithelium surrounding the ovary (Figure 3A) , whereas the ovarian stroma and the different stages of follicles were negative, similar to hilum cells. Epithelial cells of the Fallopian tube ( Figure 3B ) showed considerable immunoreactivity, whcms in stromal cells it was weak. Endometrial surface epithelium and glandular cells were positive. and stromal cells and myometrium showcd a weak reaction. A slight reaction was visible in cervical glands (not shown). Strongest immunoreactivity among all the organs of the EICHELXR, m o m , VILJA, A D -, PORSSMANN, AU-R female genital system was displayed by the syncytiotrophoblast of the placenta (at term) (Figure 3C) ; the decidual cells and the amniotic epithelium showed a clearly less intense immunoreactivity.
Skin, Nervous System, and Endocrine Glands. In the skin of the male lip (Figure 2D) , inner epithelial sheath cells of hair follicles reacted strongly, as well as subepithelial fibrocytes and endothelium of small vessels. No reaction was observed in larger vessels, smooth muscle cells, and nerves. In addition to the male lip, samples from the eyelid, scrotal skin, female scalp, and breast were studied. A weak reaction occurred in basal cell layer ofthe epidermis, basal cells of sebaceous glands, adipocyta, and fibrocyte. More intense staining was seen in myoepithelial cells from salivary (Figure 2E) and mammary glands (Figure 3D) . A very strong reaction was displayed by the cells of the inner epithelial sheath of the hair follicles of terminal hair at all of the locations.
In brain, pyramidal nerve cells of the cerebral cortex ( Figure  2F tuitary, thyroid and parathyroid, Langerhans' pancreatic islets. and endocrine gut cells were negative. A medium reaction was seen in adrenal cortical cells, particularly of the zona glomerulosa. The medulla was negative.
Immune System, Heart, and Vessels. No immunoreaction was seen in thymus, lymph nodes, spleen, and tonsils, nor in heart muscle nor skeletal muscle cells. Fat cells surrounding small vessels and endothelium of those vessels were positive, whereas endothelium of larger vessels was negative.
Respiratory System. Upper respiratory tract did not contain positive elements (with the exception of tracheobronchial glands). No immunoreactivity was seen in the lung.
Urinary System. In kidney, podocytes within the glomemli were slightly stained. Epithelial cells of the proximal and distal tubules showed positive immunoreaction. It was in the background range in the collecting tubules, and transitional epithelium of urinary pathways was completely negative. Animal Tissues. Canine prostate remained unstained after immunostaining with the L4-5 antibody. A positive reaction was seen in hepatocytes from male and female rats. Subcellular Localization. A11 cells and tissues showing a more or less strong immunoreaction displayed preferential cytoplasmic and weak nuclear staining. This distribution pattem resembled the staining pattem obtained with an antibody against rat liver 5areductase in rat hepatocytes (9). It reflected the microsomal origin of the enzyme in these tissues.
Discussion
Eficiency of the Dzferent Antibody Production Procedures
Comparing the different methods of antibody production (MAP, KLH conjugated, native peptide), MAP-conjugated antigens were shown to be an effective way of producing specific antibodies. No major differences, however, were observed both in titer levels and titer increase with the different antigen conjugates used. Antibodies obtained from different animals gave similar results both in immunohistochemical reactions and on Westem blots; differences were seen in sensitivity. A careful selection of the antibodies used for further studies is therefore essential. In our previous experiments (7) we used the interference of the antibody with enzymatic activity of the respective antigen. This was not feasible in the present case, in that no inhibitory or activating dfects were observed when microsomal preparations were incubated with the respective antibody. As a means to idenufy the most specific antibody, dilution series were performed in immunohistochemical stainings.
Antibody Specificity
In all the sera tested, antibody specificity for the C-terminal peptide sequence of human Sa-reductase 2 was high. In ELISA experiments, no significant crossreactivity of any of the antisera with C-terminal peptide of human Sa-reductase 1 could be shown, despite the 58% homology of the respective antigen (2) . Conversely, crossreactivity with a C-terminal peptide from rat hepatic 5areductase 1 (with 67% homology) was found in all antisera with the exception of serum L3. The peptides of human Sa-reductase 2 and rat Sa-reductase 1 used for immunization and testing of specificity share a common sequence stretch (FEDYPKS). A homologous stretch present in the human Sa-reductase 1 peptide is altered by exchange of two amino acids. These changes in homology in human 5a-reductase Type 1 and Type 2 are obviously sufficient to delete any crossreactivity between the respective antibodies. These findings were supported by the Western blotting results. Sera directed against human Sa-reductase 2 interacted with a protein of 26 KD from human prostate. This is similar to that of the rat liver reductase 1 previously shown by Western blotting with a specific peptide antibody (7) . The latter protein is not reactive with an antibody directed against human Sa-reductase 1 that recognizes a slightly smaller protein of 23 KD (8) . Biochemical fmdings of crossreactivity of the antisera against 5a-reductase 2 with the rat liver enzyme were confirmed by immunohistochemistry: with the exception of sera L3 and K5 (with negative or weak reaction in ELISA and Western blotting), which did not stain hepatocytes, the sera recognized rat liver Sa-reductase in situ.
fissue Distribution
Biochemical studies have indicated the presence of Sa-reductase activity in a number of cells, tissues, and organs in the genital and the extragenital system of both male and female. The recent work of Normington and Russell (20) has partly corroborated these findings at the mRNA level in young rats. They found a predominance of mRNA encoding the Type 2 isoenzyme in male genital tissues, whereas the Type 1 mRNAs predominated in peripheral tissues. Type 2 mRNA was expressed at higher levels in testis, epididymis, and vas deferens, whereas Type 1 mRNA was slightly more abundant in ventral prostate and seminal vesicle. In liver, lung, muscle, spleen, stomach, and ovaries, no Type 2 mRNA was detected. In heart, neither Type 1 nor Type 2 mRNA was found, whereas in brain and adrenal both types were present. The present report, using a specific antibody against human Type 2 Sa-reductase, shows a distribution pattem of the enzyme that is at variance with the mRNA studies in rat organs published by Normington and Russell (20) and is more related to the previously published distribution pattern of the human androgen receptor (14, 23) . There is a particularly good correspondence with the findings of Kimura et al. (14) , the essential discrepancy being skeletal and heart muscle, myometrium, &an stromal cells, and pituitary gland. The latter were negative for Sa-reductase but strongly positive for androgen receptor immunoreactivity. In testis, results were rather divergent in different studies for androgen receptor. We found a specific immunoreactivity almost exclusively in spermatogonia. The distribution pattern found in prostate may be of considerable physiological significance. Immunoreactivity was present in stromal (smooth muscle, connective tissue, endothelial, and fat) cells and in epithelium. In epithelium, basal cells were clearly more immunoreactive than glandular cells. Conversely, the reverse situation was true for androgen receptor immunoreactivity. In normal prostate, the secretory cell nuclei showed stronger androgen receptor immunoreactivity rather than those of the basal cells, which are usually negative (14, (23) (24) (25) . Only under certain conditions do the basal cells start expressing androgen receptor immunoreactivity (5) . Provided that stronger immunoreactivity for Sa-reductase is equivalent to higher enzymic activity, one might deduce from these findings a higher dihydrotestosterone synthesis in basal cells, which would perhaps provide the glandular cells with this highly hormonally active compound. In seminal vesicle, no such difference in immunoreactivity was found in basal and secretory cells. However, in epididymal epithelium, the basal cells were also more immunoreactive than principal cells.
A similar distribution pattem was seen in the hair follicle, where strong immunoreactivity was found in the inner epithelial root sheath, while the androgen receptor was localized to the neighboring outer epithelial root sheath (4, 18) .
The expression of Sa-reductase immunoreactivity in cenual nervous system is obviously restricted to special neurons. More meticulous studies are under way to analyze the topographic distribution of immunoreactive cells.
Ce ZZuZar Localization
In previous biochemical studies (10) we found Sa-reductase activity of rat ventral prostate restricted to the nuclear envelope, especially the outer nuclear membrane. Conversely, the rat hepatic enzyme appeared as a peripheral protein related to the perinuclear membranes within rat hepatocytes. Findings of Houston et al. (13) in human prostate also pointed to a nuclear membrane-linked location of the enzyme, suggesting that the microsomal enzyme activities seen in cell fractionating experiments were due to crosscontamination of the membrane vesicles during homogenization of the tissue. Using an antibody against rat hepatic Sa-reductase, we could localize the respective antigen closely, although not exclusively, to the nuclei, perhaps within the nuclear envelope and the endoplasmic reticulum (7, 9) . The antibody against the rat hepatic enzyme, however, failed to show any crossreactive material in rat prostate epithelium. In the present immunohistochemical studies, the localization of the enzyme appeared preferentially cytoplasmic, especially in prostate epithelial cells. Some nuclear staining, which was never exclusive, was seen in a number of tissues. This therefore suggests the perinuclear ergastoplasm as the localization site of the Sa-reductase 2 enzyme.
Sexud Dimorp h i m
5a-Reductase 2 is not restricted to the male but is present in considerable amounts in the female and in placenta. There is a good concordance, both in epithelium of mammary gland and in syncytiotrophoblast, between the localization of the androgen receptor (14) and Sa-reductase. Discrepancies in the distribution pattern of Sa-reductase, as shown in this report, and the androgen receptor reported by different authors may be due to the sensitivity of the antibodies used or the masking of epitopes as a result of fixation procedures. On the other hand, differences in the distribution pattem of 5a-reductase and androgen receptor could have physiological significance, e.g., in the uterus, whereas the androgen receptor is present in myometrium and stromal cells but 5areductase immunoreactivity is either absent or weak. These findings point to the possibility that la-reductase has a dual function in the aforementioned cells on one hand, and in placental and mammary cells on the other hand. It would be conceivable that the enzyme is involved in the reductive androgen pathway in certain tissues and in progesterone metabolism in others, as progesterone and other 4-5-saturated steroids are substrates with high affinity to 5areductases (3, 19) . This would imply that the previous suggestion of Normington and Russell (20) of an anabolic role of Type 2 enzyme and a more catabolic role of Type 1 enzyme in the metabolism of androgens and other steroid hormones, must be extended with regard to the significance of enzyme 2. Studies under way, comparing enzyme activity, mRNA distribution, and immunohistochemical localization of Sa-reductase and the androgen receptor, will help to clarify the situation.
